-
Product Insights
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Report Overview A total of 704 post-traumatic stress disorder (PTSD) clinical trials were conducted as of January 2024. The PTSD clinical trial report provides a comprehensive understanding of the PTSD clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       North...
-
Product Insights
Social Anxiety Disorder (SAD/Social Phobia) – Drugs In Development, 2023
Global Markets Direct’s, ‘Social Anxiety Disorder (SAD/Social Phobia) - Drugs In Development, 2023’, provides an overview of the Social Anxiety Disorder (SAD/Social Phobia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Social Anxiety Disorder (SAD/Social Phobia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Panic Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Panic Disorders - Drugs In Development, 2023’, provides an overview of the Panic Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Panic Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Obsessive-Compulsive Disorder – Drugs In Development, 2023
Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Drugs In Development, 2023’, provides an overview of the Obsessive-Compulsive Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Obsessive-Compulsive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Post-Traumatic Stress Disorder (PTSD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Post-Traumatic Stress Disorder (PTSD) - Drugs In Development, 2023’, provides an overview of the Post-Traumatic Stress Disorder (PTSD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post-Traumatic Stress Disorder (PTSD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Generalized Anxiety Disorder (GAD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Generalized Anxiety Disorder (GAD) - Drugs In Development, 2023’, provides an overview of the Generalized Anxiety Disorder (GAD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Generalized Anxiety Disorder (GAD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Social Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Social Anxiety Disorder (SAD/Social Phobia) Clinical Trials Market Report Overview The social anxiety disorder (SAD/social phobia) trial market research report provides an overview of the social anxiety disorder (SAD/social phobia) trials scenario. The report provides top-line data relating to the clinical trials on social anxiety disorder. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Sector Analysis
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Overview In the seven major pharmaceutical markets (7MM: France, Germany, Italy, Japan, Spain, UK and the US), GlobalData epidemiologists estimated more than 1.02 million acute diagnosed prevalent cases for PTSD in 2023. Post-Traumatic Stress Disorder (PTSD) is a mental disorder that can occur after experiencing a traumatic event. Characterized by symptoms typical of anxiety disorders such as irritability, sleep disturbances, disrupted concentration, and increased heart rate, PTSD is distinguished by the patient...
-
Sector Analysis
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Body Dysmorphic Disorder Clinical Trials Report Overview Body dysmorphic disorder (BDD), also known as dysmorphophobia, is a severe psychiatric condition in which an individual spends a significant amount of time worrying about flaws in their own or another person’s appearance. These flaws are frequently overlooked by others. BDD can affect people of any age, but it is most common in teenagers and young adults. It affects both men and women. The BDD marketed and pipeline drugs market research report includes...
-
Product Insights
Obsessive-Compulsive Disorder Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Obsessive-Compulsive Disorder Clinical Trials Market Report Overview The Obsessive-Compulsive Disorder clinical trial market research report provides an overview of the Obsessive-Compulsive Disorder clinical trials scenario. The report provides top-line data relating to the clinical trials on Obsessive-Compulsive Disorder. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....